ADVFN Logo

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

ABIO ARCA Biopharma Inc

1,77
0,02 (1,14%)
Avant marché
Dernière mise à jour : 13:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ARCA Biopharma Inc ABIO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,02 1,14% 1,77 13:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,75
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/2/202419:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202422:15EDGAR2Form 8-K - Current report
01/2/202422:39EDGAR2Form 8-K - Current report
01/2/202422:35GLOBEARCA biopharma Announces 2023 Financial Results
01/2/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/2/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:15EDGAR2Form 8-K - Current report
19/12/202322:25EDGAR2Form ARS - Annual Report to Security Holders
19/12/202322:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
05/12/202322:25EDGAR2Form 8-K - Current report
04/12/202322:36EDGAR2Form 8-K - Current report
18/10/202322:35EDGAR2Form 8-K - Current report
18/10/202322:25GLOBEARCA biopharma Announces Third Quarter 2023 Financial..
18/10/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/9/202322:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/7/202322:35EDGAR2Form 8-K - Current report
21/7/202322:25GLOBEARCA biopharma Announces Second Quarter 2023 Financial..
21/7/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/4/202322:25GLOBEARCA biopharma Announces First Quarter 2023 Financial..

Dernières Valeurs Consultées

Delayed Upgrade Clock